Mark J. Gergen
2016 - Mirati Therapeutics
In 2016, Mark J. Gergen earned a total compensation of $2M as Former Executive Vice President and Chief Operations Officer at Mirati Therapeutics, a 87% increase compared to previous year.
Compensation breakdown
Option Awards | $1,179,389 |
---|---|
Salary | $283,909 |
Other | $512,747 |
Total | $1,976,045 |
Gergen received $1.2M in option awards, accounting for 60% of the total pay in 2016.
Gergen also received $283.9K in salary and $512.7K in other compensation.
Rankings
In 2016, Mark J. Gergen's compensation ranked 4,947th out of 14,075 executives tracked by ExecPay. In other words, Gergen earned more than 64.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,947 | 65th |
Manufacturing | 1,765 | 68th |
Chemicals And Allied Products | 557 | 71st |
Drugs | 413 | 73rd |
Pharmaceutical Preparations | 328 | 72nd |
Gergen's colleagues
We found five more compensation records of executives who worked with Mark J. Gergen at Mirati Therapeutics in 2016.
2016
Charles Baum
Mirati Therapeutics
Chief Executive Officer
2016
James Christensen
Mirati Therapeutics
Chief Scientific Officer
2016
Isan Chen
Mirati Therapeutics
Executive Vice President and Chief Medical and Development Officer
2016
Jamie Donadio
Mirati Therapeutics
Chief Financial Officer
2016
Chris LeMasters
Mirati Therapeutics